We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI Helps Identify and Treat Irritable Bowel Syndrome

By MedImaging International staff writers
Posted on 20 Jan 2014
British scientists are utilizing magnetic resonance imaging (MRI) technology to assist in the treatment and diagnosis of irritable bowel syndrome (IBS), a disorder that causes serious discomfort and distress to sufferers.

In three separate studies, researchers examined the disorder and found another way of examining the condition, which could have major implications in how it is both diagnosed and treated in the future.

The three studies explored the effectiveness of using MRI to evaluate the colon, which has a number of novel advantages. Before this, clinicians have relied on -rays to view the colon, which has limitations due to the risks tied to radiation. By using MRI as an alternative, the researchers have been able to image the bowel continuously with no risk to the patient, enabling them to learn more about the inner workings of the gut.

The research has been led by researchers from the University of Nottingham’s (UK) Digestive Diseases Center (NDDC) and scientists from the Sir Peter Mansfield Magnetic Resonance Center at the University. In the first study, published in the January 2014 issue of the journal Neurogastroenterology and Motility, scientists were able to image the colon and split it in to three functional regions: the ascending colon, which is a storage and fermentation region, where unabsorbed residue is broken down by bacteria; the transverse colon, which is a storage area for the residue left after bacterial processing, and the descending colon, which is an organ that pushes waste down and out of the body.

Using MRI, scientists can also measure the volumes of these regions, which they have never been able to do before. Prof. Robin Spiller, lead director of Nottingham digestive diseases biomedical research unit, said, “We studied people with accelerated transit and to our surprise, we found that the colon size was rather similar to those with normal transit suggesting people regulate their bowel habit to keep the colonic size constant. We also know that when you eat a meal the ascending colon expands as the meal is pushed down into it to make space in the small bowel for the new meal. We found that this increase was smaller in IBS patients than in healthy volunteers, suggesting that the IBS patient’s ascending colon can’t relax enough. With MRI, we can actually measure this change in a way that we’ve never been able to do before. This will have other benefits in the future, for instance we will be able to measure the effect of some drugs on the bowel.”

In the second study, published in the January 2014 issue of the journal Neurogastroenterology and Motility, scientists used MRI scanning to gauge the actual time it takes for contents to transit the bowel, using specially designed MRI visible markers, which subjects ingest. Scientists can then image the bowel 24 hours later to see how far they have moved. Previously, motility had to be measured using X-rays, which has extremely limited the circumstances when the measurement could be made.

In the third study, published online November 19, 2013, in American Journal of Gastroenterology, researchers used the colonic imaging technique again, but this time, to improve their understanding of the causes of IBS. By looking at fructose, a sugar commonly found in fruit, and fructans, which are polymers of fructose, researchers were able see what effects these had on the gut of healthy study participants. “We already know that fructose is difficult to absorb, but the novelty with this new method, is that we are now able to image the end effect of this malabsorption which is the distension of the small intestine and colon. We are currently repeating these studies in patients with IBS to see whether their symptoms correlate with the distension of the colon.”

Fructans and fructose are part of a group of chemicals called FODMAPs (fermentable oligo, di- monosaccharides and polyhydric) alcohols, whose characteristics are that they are comparatively tough to absorb, but they are fermentable, so when they go in to the colon they are exposed to the bacteria and produce gas.

Prof. Spiller continued, “It’s been found that diets that restrict the intake of these things improve symptoms and our MRI studies show us scientifically why that improvement might occur. We were able to show that while fructose alone was poorly absorbed and distended the small bowel, when it was combined with glucose the poor absorption was prevented. We also found that fructans have little effect in the small bowel but a large effect on the colon. In future, will be able to use our MRI techniques to test specific foods to understand how they will affect IBS.

“By defining the link between the chemistry of food to its impact on the bowel our technique will enable us to answer specific questions, e.g., when an apple ripens and the sugar content rise, does the adverse effect reduce? This might explain why green apples can cause stomachache while ripe ones do not. The fructose in the green apple is malabsorbed but as it ripens the glucose content rises improves fructose absorption, improving the rate of absorption.”

Related Links:

University of Nottingham 

Ultrasonic Pocket Doppler
SD1
Half Apron
Demi
Ultrasound Table
Women’s Ultrasound EA Table
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro

Channels

General/Advanced Imaging

view channel
Image: Example snapshots of the photon energy density at t = 0.5, 0.7, 0.9, 1.1 nanoseconds (ns) on the y = 2.0 cm plane (Horie, S., Yajima, H., Abe, M. et al., Biomedical Engineering Letters (2026). DOI: 10.1007/s13534-026-00578-9)

AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection

Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.